Evidence map›Paper›PMID 37367687›Full record

ArticleMarine drugs2023

New Antibacterial Diterpenoids from the South China Sea Soft Coral

Jia-Dong Yu, Dan-Dan Yu, Ming-Zhi Su, Yu-Cheng Gu, Hong Wang, Yue-Wei Guo

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jia-Dong YuCollege of Pharmaceutical Science and Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China.
Dan-Dan YuShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China.
Ming-Zhi SuShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, China.ORCID 0009-0004-8805-3963
Yu-Cheng GuSyngenta, Jealott's Hill International Research Centre, Bracknell RG42 6EY, Berkshire, UK.ORCID 0000-0002-6400-6167
Hong WangCollege of Pharmaceutical Science and Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China.ORCID 0000-0003-0058-060X
Yue-Wei GuoCollege of Pharmaceutical Science and Collaborative Innovation Center of Yangtze River Delta Region Green Pharmaceuticals, Zhejiang University of Technology, Hangzhou 310014, China.ORCID 0000-0003-0413-2070

Funding

National Key Research and Development Program of China 2022YFC2804100National Natural Science Foundation of China 41876194National Natural Science Foundation of China 81991521SKLDR/SIMM Project SIMM2103ZZ-06
6 · The paper itself

Abstract

Fifteen new diterpenoids, namely xishaklyanes A-O (

Indexed as

AnthozoaDiterpenesAnimalsAnti-Bacterial AgentsChinaMolecular StructureAnti-Bacterial AgentsDiterpenesantibacterial activityditerpenoidsKlyxum mollesoft coralstereochemistry

Identifiers

PMID37367687
PMCPMC10304424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.